1Bosscher D, Breynaert A, Pieters L, et al. Food- based strategies to modulate the composition of the intestinal microbiota and their associated health effects[J]. J Physiol Pharmaeol, 2009, Suppl 6: 5-11.
3Kaysen GA. The microinflammatory state in uremia: causes and potential consequences[J]. J Am Soc Nephrol, 2001, 12: 1549-1557.
4Miyamoto T, Carrero JJ, Stenvinkel P. Inflammation as a risk factor and target for therapy in chronic kidney disease[J]. Curr Opin Nephrol I-Iypertens, 2011, 20: 662-668.
5Tsao YT, Hsu YJ, Chu NF, et al. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis[J]. J Nephrol, 2008, 21: 744-752.
6Buranakarl C, Trisiriroj M, Pondeenana S, et al. Relationships between oxidative stress markers and red blood cell characteristics in renal azotemie dogs[J]. Res Vet Sci, 2009, 86: 309-313.
7Massy ZA, Stenvinkel P, Drueke TB. The role of oxidative stress in chronic kidney disease[J]. Semin Dial, 2009, 22: 405- 408.
8Suzuki Y, Ruiz-Ortega M, Lorenzo O, et al. Inflammation and angiotensin II[J]. Int J Bioehem Cell Biol, 2003, 35:881-900.
9Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes[J]. Annu Rev Med, 2011, 62: 361-380.
10Rinttila T, Kassinen A, Malinen E, et al. Development of an extensive set of 16S rDNA targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR[J]. J Appl Microbiol, 2004, 97:1166 -1177.
